Avanir Pharmaceuticals, Inc. (AVNR) was a big mover last session, as the company saw its shares rise over 16% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the past one month’s volatile price range of $3.45 to $4.29.
This biopharmaceutical company has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s sharp climb is encouraging though, so make sure to keep a close watch on this firm in the near future.
Avanir currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Some better-ranked Med-Drug stocks worth considering are Lannett Company, Inc. (LCI), Questcor Pharmaceuticals, Inc. (QCOR) and Shire plc (SHPG). All these stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment